In VivoL-DOPA Production by Genetically Modified Primary Rat Fibroblast or 9L Gliosarcoma Cell Grafts via Coexpression of GTPcyclohydrolase I with Tyrosine Hydroxylase
- 30 June 1998
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 151 (2) , 249-264
- https://doi.org/10.1006/exnr.1998.6803
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Retroviral Particles Produced from a Stable Human-Derived Packaging Cell Line Transduce Target Cells with Very High EfficienciesHuman Gene Therapy, 1997
- Practical Aspects of the Development ofex Vivoandin VivoGene Therapy for Parkinson's DiseaseExperimental Neurology, 1997
- Dopaminergic Neurons Protected from Degeneration by GDNF Gene TherapyScience, 1997
- Double Transduction with GTP Cyclohydrolase I and Tyrosine Hydroxylase Is Necessary for Spontaneous Synthesis ofl-DOPA by Primary FibroblastsJournal of Neuroscience, 1996
- Long-Term Behavioral Recovery in Parkinsonian Rats by an HSV Vector Expressing Tyrosine HydroxylaseScience, 1994
- Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned ratExperimental Brain Research, 1994
- Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopaNeuron, 1991
- Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.Proceedings of the National Academy of Sciences, 1988
- Grafting genetically modified cells to the brain: Possibilities for the futureNeuroscience, 1987
- Dopamine-rich transplants in rats with 6-OHDA lesions of the ventral tegmental area. I. Effects on spontaneous and drug-induced locomotor activityBehavioural Brain Research, 1984